Document is current
Any future updates will be listed below
-
Authors
Wang, Wenzhi
She, Tianyu
Wang, Yuan
Wang, Fei
Wang, Menglu
Xu, Shichuan
Duan, Xiaoyi
Yang, Liping
-
Funding
Funding for this research was provided by:
Haiyan Fund of Harbin Medical University Cancer Hospital (JJMS-2023-05)
- License Information
-
More Information
Article History
Received: 10 May 2025
Accepted: 7 November 2025
First Online: 12 January 2026
Declarations
:
: The prospective enrollment of healthy controls was approved by the IRB of Harbin Medical University Cancer Hospital (approval number: JS2021-10) in accordance with the Declaration of Helsinki (2013 revision). Written informed consent was obtained for all contrast-enhanced CMR procedures. For the retrospective patient cohort, the IRB waived the requirement for individual consent given the anonymized use of pre-existing clinical data.
: Informed consent was waived by the Ethics Committee for the retrospective patient cohort. Written informed consent was obtained from all prospectively enrolled healthy control participants.T.
: Not applicable.
: The authors declare no competing interests.
